Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus

This study has been completed.
Biogen Idec
Information provided by (Responsible Party):
UCB Pharma Identifier:
First received: January 2, 2013
Last updated: August 26, 2014
Last verified: August 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)